最新报道:FB Capital's Mike Bailey highlights three stocks poised to outperform Wall Street expectations, citing strong fundamentals and market positioning. Tech giant Innovent (INVT) leads with robust AI-driven growth, while healthcare firm BioGenix (BGX) benefits from breakthrough drug approvals. Financial services provider Vertex Capital (VTC) rounds out the list, leveraging fintech adoption trends. Bailey notes these companies exhibit above-average earnings momentum and sector tailwinds, making them likely to exceed Q2 estimates. Analysts project 15-20% upside potential across the trio based on revised guidance and expanding addressable markets. The picks reflect FB Capital's focus on innovation-driven value stocks in current market conditions.